Eli Lilly and (LLY) Price/FCF Ratio: History & Chart

Eli Lilly and Company (LLY)LLYEli Lilly and Company

About Eli Lilly and Company

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

Indianapolis, IN

50,000 employees

www.lilly.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: David A. Ricks

View full financials

LLY Price/FCF Ratio Metrics

PRICE/FCF RATIO

78.91

PRICE/FCF RATIO AVG TTM

91.17

PRICE/FCF RATIO AVG 3Y

110.18

PRICE/FCF RATIO AVG 5Y

77.98

PRICE/FCF RATIO AVG 10Y

41.95

PRICE/FCF RATIO AVG 15Y

34.48

PRICE/FCF RATIO AVG 20Y

28.69

CURRENT VS TTM AVG

-13.44%

CURRENT VS 3Y AVG

-28.38%

CURRENT VS 5Y AVG

+1.19%

CURRENT VS 10Y AVG

+88.09%

CURRENT VS 15Y AVG

+128.87%

CURRENT VS 20Y AVG

+175.08%

SECTOR MEDIAN · HEALTHCARE

19.73

median of 74 covered companies

CURRENT VS SECTOR MEDIAN

+300.05%

vs the sector median at left

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Eli Lilly and Company (LLY)	$1.13T	78.91	91.17	110.18	77.98
Johnson & Johnson (JNJ)vs ›	$634.06B	28.42	28.62	24.17	23.74
AbbVie Inc. (ABBV)vs ›	$458.11B	22.05	20.17	17.39	15.00
UnitedHealth Group Incorporated (UNH)vs ›	$382.09B	16.14	15.82	26.50	24.02
Merck & Co., Inc. (MRK)vs ›	$323.72B	22.95	19.28	20.90	21.42
AstraZeneca PLC (AZN)vs ›	$262.31B	16.37	16.02	15.91	16.92
Novo Nordisk A/S (NVO)vs ›	$216.72B	44.75	32.87	43.55	39.02
Thermo Fisher Scientific Inc. (TMO)vs ›	$211.18B	28.81	31.10	29.71	30.74
Amgen Inc. (AMGN)vs ›	$202.95B	23.80	18.66	19.72	18.07
Abbott Laboratories (ABT)vs ›	$179.58B	24.40	28.29	33.29	29.65

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Eli Lilly and Company (LLY)

$1.13T

78.91

91.17

110.18

77.98

Johnson & Johnson (JNJ)vs ›

$634.06B

28.42

28.62

24.17

23.74

AbbVie Inc. (ABBV)vs ›

$458.11B

22.05

20.17

17.39

15.00

UnitedHealth Group Incorporated (UNH)vs ›

$382.09B

16.14

15.82

26.50

24.02

Merck & Co., Inc. (MRK)vs ›

$323.72B

22.95

19.28

20.90

21.42

AstraZeneca PLC (AZN)vs ›

$262.31B

16.37

16.02

15.91

16.92

Novo Nordisk A/S (NVO)vs ›

$216.72B

44.75

32.87

43.55

39.02

Thermo Fisher Scientific Inc. (TMO)vs ›

$211.18B

28.81

31.10

29.71

30.74

Amgen Inc. (AMGN)vs ›

$202.95B

23.80

18.66

19.72

18.07

Abbott Laboratories (ABT)vs ›

$179.58B

24.40

28.29

33.29

29.65

Price/FCF Ratio FAQ

What is the Price/FCF ratio for Eli Lilly and Company (LLY)?

The Price/FCF ratio for LLY stock is 78.91.

Is Eli Lilly and Company's Price/FCF ratio high or low?

The Price/FCF ratio of 78.91 is 52% below its 5-year average of 164.70, near the low end of its 5-year range (41.71–1643.86).

What is the TTM average Price/FCF ratio for Eli Lilly and Company (LLY)?

The TTM average Price/FCF ratio for LLY stock is 91.17.

What is the 3Y average Price/FCF ratio for Eli Lilly and Company (LLY)?

The 3Y average Price/FCF ratio for LLY stock is 110.18.

What is the 5Y average Price/FCF ratio for Eli Lilly and Company (LLY)?

The 5Y average Price/FCF ratio for LLY stock is 77.98.

What is the 10Y average Price/FCF ratio for Eli Lilly and Company (LLY)?

The 10Y average Price/FCF ratio for LLY stock is 41.95.

What is the 15Y average Price/FCF ratio for Eli Lilly and Company (LLY)?

The 15Y average Price/FCF ratio for LLY stock is 34.48.

What is the 20Y average Price/FCF ratio for Eli Lilly and Company (LLY)?

The 20Y average Price/FCF ratio for LLY stock is 28.69.

DATE	PRICE/FCF RATIO
2026-07-24	78.91
2026-07-23	78.23
2026-07-22	76.73
2026-07-21	77.54
2026-07-20	75.66
2026-07-17	77.79
2026-07-16	77.13
2026-07-15	76.31
2026-07-14	76.04
2026-07-13	77.97
2026-07-10	78.41
2026-07-09	80.29
2026-07-08	80.21
2026-07-07	81.51
2026-07-06	79.17
2026-07-02	80.08
2026-07-01	78.62
2026-06-30	79.13
2026-06-29	81.14
2026-06-26	79.70
2026-06-25	74.40
2026-06-24	73.71
2026-06-23	73.04
2026-06-22	72.71
2026-06-18	72.48
2026-06-17	73.36
2026-06-16	74.05
2026-06-15	74.51
2026-06-12	74.75
2026-06-11	76.59
2026-06-10	74.97
2026-06-09	75.52
2026-06-08	75.81
2026-06-05	74.64
2026-06-04	74.24
2026-06-03	71.17
2026-06-02	70.20
2026-06-01	71.40
2026-05-29	72.90
2026-05-28	74.34
2026-05-27	71.44
2026-05-26	70.24
2026-05-22	70.26
2026-05-21	68.72
2026-05-20	67.22
2026-05-19	67.38
2026-05-18	65.19
2026-05-15	66.30
2026-05-14	66.41
2026-05-13	67.01
2026-05-12	65.30
2026-05-11	63.79
2026-05-08	62.57
2026-05-07	64.32
2026-05-06	65.12
2026-05-05	65.24
2026-05-04	63.86
2026-05-01	63.55
2026-04-30	61.66
2026-04-29	85.20
2026-04-28	87.48
2026-04-27	86.90
2026-04-24	88.48
2026-04-23	91.85
2026-04-22	92.23
2026-04-21	90.38
2026-04-20	92.07
2026-04-17	92.79
2026-04-16	90.48
2026-04-15	90.58
2026-04-14	92.33
2026-04-13	93.04
2026-04-10	94.03
2026-04-09	95.60
2026-04-08	95.42
2026-04-07	93.19
2026-04-06	92.79
2026-04-02	93.64
2026-04-01	95.54
2026-03-31	92.06
2026-03-30	88.74
2026-03-27	87.90
2026-03-26	89.78
2026-03-25	91.71
2026-03-24	90.38
2026-03-23	91.14
2026-03-20	90.75
2026-03-19	91.83
2026-03-18	91.89
2026-03-17	93.12
2026-03-16	99.00
2026-03-13	98.60
2026-03-12	97.81
2026-03-11	100.07
2026-03-10	100.22
2026-03-09	100.93
2026-03-06	99.12
2026-03-05	98.41
2026-03-04	100.45
2026-03-03	100.86
2026-03-02	101.89
2026-02-27	105.29
2026-02-26	102.29
2026-02-25	102.97
2026-02-24	104.31
2026-02-23	105.95
2026-02-20	101.04
2026-02-19	102.41
2026-02-18	102.15
2026-02-17	103.70
2026-02-13	104.09
2026-02-12	103.92
2026-02-11	101.15
2026-02-10	102.09
2026-02-09	104.09
2026-02-06	105.43
2026-02-05	101.71
2026-02-04	110.31
2026-02-03	99.98
2026-02-02	104.03
2026-01-30	103.34
2026-01-29	102.04
2026-01-28	102.01
2026-01-27	103.57
2026-01-26	105.89
2026-01-23	106.04
2026-01-22	108.34
2026-01-21	107.46
2026-01-20	103.75
2026-01-16	103.46
2026-01-15	102.92
2026-01-14	106.94
2026-01-13	107.33
2026-01-12	107.71
2026-01-09	105.97
2026-01-08	108.13
2026-01-07	110.41
2026-01-06	106.02
2026-01-05	103.77
2026-01-02	107.64
2025-12-31	107.08
2025-12-30	107.58
2025-12-29	107.55
2025-12-26	107.38
2025-12-24	107.31
2025-12-23	106.78
2025-12-22	107.26
2025-12-19	106.76
2025-12-18	105.30
2025-12-17	103.80
2025-12-16	105.05
2025-12-15	105.83
2025-12-12	102.38
2025-12-11	100.57
2025-12-10	99.00
2025-12-09	97.87
2025-12-08	99.40
2025-12-05	100.66
2025-12-04	101.08
2025-12-03	102.98
2025-12-02	104.23
2025-12-01	105.41
2025-11-28	107.16
2025-11-26	110.03
2025-11-25	110.59
2025-11-24	106.63
2025-11-21	105.59
2025-11-20	103.95
2025-11-19	104.58
2025-11-18	102.63
2025-11-17	101.80
2025-11-14	102.16
2025-11-13	101.92
2025-11-12	101.41
2025-11-11	98.50
2025-11-10	96.31
2025-11-07	92.10
2025-11-06	93.40
2025-11-05	92.25
2025-11-04	90.36
2025-11-03	89.33
2025-10-31	85.97
2025-10-30	84.14
2025-04-30	1589.46
2025-04-29	1565.14
2025-04-28	1551.16
2025-04-25	1563.98
2025-04-24	1520.11
2025-04-23	1466.20
2025-04-22	1463.19
2025-04-21	1446.36
2025-04-17	1485.15
2025-04-16	1299.39
2025-04-15	1338.79
2025-04-14	1333.78
2025-04-11	1294.99
2025-04-10	1274.66
2025-04-09	1332.65
2025-04-08	1284.08
2025-04-07	1279.64
2025-04-04	1305.25
2025-04-03	1395.21
2025-04-02	1446.71
2025-04-01	1423.75
2025-03-31	1460.31
2025-03-28	1454.30
2025-03-27	1452.81
2025-03-26	1461.81
2025-03-25	1507.06
2025-03-24	1529.25
2025-03-21	1480.93
2025-03-20	1489.77
2025-03-19	1479.94
2025-03-18	1454.30
2025-03-17	1458.28
2025-03-14	1438.33
2025-03-13	1417.42
2025-03-12	1453.15
2025-03-11	1457.04
2025-03-10	1467.12
2025-03-07	1537.53
2025-03-06	1613.87
2025-03-05	1643.86
2025-03-04	1610.87
2025-03-03	1643.86
2025-02-28	1627.79
2025-02-27	1600.44
2025-02-26	1617.85
2025-02-25	1594.49
2025-02-24	1558.42
2025-02-21	1544.78
2025-02-20	1543.78
2025-02-19	1533.05
2023-11-01	163.90
2023-10-31	163.74
2023-10-30	167.22
2023-10-27	165.60
2023-10-26	167.93
2023-10-25	173.36
2023-10-24	175.12
2023-10-23	170.46
2023-10-20	172.82
2023-10-19	174.64
2023-10-18	179.50
2023-10-17	179.82
2023-10-16	182.28
2023-10-13	180.08
2023-10-12	180.46
2023-10-11	178.92
2023-10-10	171.24
2023-10-09	169.01
2023-10-06	167.08
2023-10-05	160.06
2023-10-04	157.10
2023-10-03	155.25
2023-10-02	159.12
2023-09-29	158.77
2023-09-28	160.94
2023-09-27	162.51
2023-09-26	162.58

DATE

PRICE/FCF RATIO

2026-07-24

78.91

2026-07-23

78.23

2026-07-22

76.73

2026-07-21

77.54

2026-07-20

75.66

2026-07-17

77.79

2026-07-16

77.13

2026-07-15

76.31

2026-07-14

76.04

2026-07-13

77.97

2026-07-10

78.41

2026-07-09

80.29

2026-07-08

80.21

2026-07-07

81.51

2026-07-06

79.17

2026-07-02

80.08

2026-07-01

78.62

2026-06-30

79.13

2026-06-29

81.14

2026-06-26

79.70

2026-06-25

74.40

2026-06-24

73.71

2026-06-23

73.04

2026-06-22

72.71

2026-06-18

72.48

2026-06-17

73.36

2026-06-16

74.05

2026-06-15

74.51

2026-06-12

74.75

2026-06-11

76.59

2026-06-10

74.97

2026-06-09

75.52

2026-06-08

75.81

2026-06-05

74.64

2026-06-04

74.24

2026-06-03

71.17

2026-06-02

70.20

2026-06-01

71.40

2026-05-29

72.90

2026-05-28

74.34

2026-05-27

71.44

2026-05-26

70.24

2026-05-22

70.26

2026-05-21

68.72

2026-05-20

67.22

2026-05-19

67.38

2026-05-18

65.19

2026-05-15

66.30

2026-05-14

66.41

2026-05-13

67.01

2026-05-12

65.30

2026-05-11

63.79

2026-05-08

62.57

2026-05-07

64.32

2026-05-06

65.12

2026-05-05

65.24

2026-05-04

63.86

2026-05-01

63.55

2026-04-30

61.66

2026-04-29

85.20

2026-04-28

87.48

2026-04-27

86.90

2026-04-24

88.48

2026-04-23

91.85

2026-04-22

92.23

2026-04-21

90.38

2026-04-20

92.07

2026-04-17

92.79

2026-04-16

90.48

2026-04-15

90.58

2026-04-14

92.33

2026-04-13

93.04

2026-04-10

94.03

2026-04-09

95.60

2026-04-08

95.42

2026-04-07

93.19

2026-04-06

92.79

2026-04-02

93.64

2026-04-01

95.54

2026-03-31

92.06

2026-03-30

88.74

2026-03-27

87.90

2026-03-26

89.78

2026-03-25

91.71

2026-03-24

90.38

2026-03-23

91.14

2026-03-20

90.75

2026-03-19

91.83

2026-03-18

91.89

2026-03-17

93.12

2026-03-16

99.00

2026-03-13

98.60

2026-03-12

97.81

2026-03-11

100.07

2026-03-10

100.22

2026-03-09

100.93

2026-03-06

99.12

2026-03-05

98.41

2026-03-04

100.45

2026-03-03

100.86

2026-03-02

101.89

2026-02-27

105.29

2026-02-26

102.29

2026-02-25

102.97

2026-02-24

104.31

2026-02-23

105.95

2026-02-20

101.04

2026-02-19

102.41

2026-02-18

102.15

2026-02-17

103.70

2026-02-13

104.09

2026-02-12

103.92

2026-02-11

101.15

2026-02-10

102.09

2026-02-09

104.09

2026-02-06

105.43

2026-02-05

101.71

2026-02-04

110.31

2026-02-03

99.98

2026-02-02

104.03

2026-01-30

103.34

2026-01-29

102.04

2026-01-28

102.01

2026-01-27

103.57

2026-01-26

105.89

2026-01-23

106.04

2026-01-22

108.34

2026-01-21

107.46

2026-01-20

103.75

2026-01-16

103.46

2026-01-15

102.92

2026-01-14

106.94

2026-01-13

107.33

2026-01-12

107.71

2026-01-09

105.97

2026-01-08

108.13

2026-01-07

110.41

2026-01-06

106.02

2026-01-05

103.77

2026-01-02

107.64

2025-12-31

107.08

2025-12-30

107.58

2025-12-29

107.55

2025-12-26

107.38

2025-12-24

107.31

2025-12-23

106.78

2025-12-22

107.26

2025-12-19

106.76

2025-12-18

105.30

2025-12-17

103.80

2025-12-16

105.05

2025-12-15

105.83

2025-12-12

102.38

2025-12-11

100.57

2025-12-10

99.00

2025-12-09

97.87

2025-12-08

99.40

2025-12-05

100.66

2025-12-04

101.08

2025-12-03

102.98

2025-12-02

104.23

2025-12-01

105.41

2025-11-28

107.16

2025-11-26

110.03

2025-11-25

110.59

2025-11-24

106.63

2025-11-21

105.59

2025-11-20

103.95

2025-11-19

104.58

2025-11-18

102.63

2025-11-17

101.80

2025-11-14

102.16

2025-11-13

101.92

2025-11-12

101.41

2025-11-11

98.50

2025-11-10

96.31

2025-11-07

92.10

2025-11-06

93.40

2025-11-05

92.25

2025-11-04

90.36

2025-11-03

89.33

2025-10-31

85.97

2025-10-30

84.14

2025-04-30

1589.46

2025-04-29

1565.14

2025-04-28

1551.16

2025-04-25

1563.98

2025-04-24

1520.11

2025-04-23

1466.20

2025-04-22

1463.19

2025-04-21

1446.36

2025-04-17

1485.15

2025-04-16

1299.39

2025-04-15

1338.79

2025-04-14

1333.78

2025-04-11

1294.99

2025-04-10

1274.66

2025-04-09

1332.65

2025-04-08

1284.08

2025-04-07

1279.64

2025-04-04

1305.25

2025-04-03

1395.21

2025-04-02

1446.71

2025-04-01

1423.75

2025-03-31

1460.31

2025-03-28

1454.30

2025-03-27

1452.81

2025-03-26

1461.81

2025-03-25

1507.06

2025-03-24

1529.25

2025-03-21

1480.93

2025-03-20

1489.77

2025-03-19

1479.94

2025-03-18

1454.30

2025-03-17

1458.28

2025-03-14

1438.33

2025-03-13

1417.42

2025-03-12

1453.15

2025-03-11

1457.04

2025-03-10

1467.12

2025-03-07

1537.53

2025-03-06

1613.87

2025-03-05

1643.86

2025-03-04

1610.87

2025-03-03

1643.86

2025-02-28

1627.79

2025-02-27

1600.44

2025-02-26

1617.85

2025-02-25

1594.49

2025-02-24

1558.42

2025-02-21

1544.78

2025-02-20

1543.78

2025-02-19

1533.05

2023-11-01

163.90

2023-10-31

163.74

2023-10-30

167.22

2023-10-27

165.60

2023-10-26

167.93

2023-10-25

173.36

2023-10-24

175.12

2023-10-23

170.46

2023-10-20

172.82

2023-10-19

174.64

2023-10-18

179.50

2023-10-17

179.82

2023-10-16

182.28

2023-10-13

180.08

2023-10-12

180.46

2023-10-11

178.92

2023-10-10

171.24

2023-10-09

169.01

2023-10-06

167.08

2023-10-05

160.06

2023-10-04

157.10

2023-10-03

155.25

2023-10-02

159.12

2023-09-29

158.77

2023-09-28

160.94

2023-09-27

162.51

2023-09-26

162.58

Price/FCF Ratio: 78.91

LLY Price/FCF Ratio Chart

LLY Average Price/FCF Ratio Chart

LLY Current vs Average Price/FCF Ratio Chart

LLY Price/FCF Ratio Metrics

LLY Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

LLY Price/FCF Ratio History

Related Metrics